Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-06-02 Calcium-channel blockers
| Nifedipine |
|
Formulary
|
M/R Tablets 10mg, 20mg (prescribe modified-release preparations by brand)
Capsules 5mg, 10mg, 20mg (use of immediate-release capsules may be associated with large variations in blood pressure and reflex tachycardia)
Nifedipine immediate-release capsules are no longer recommended for the treatment of angina or hypertension.
Refer to the individual SPC for each preparation of nifedipine for further details on use in preganancy.
Nifedipine is used in Raynaud's syndrome (modified release preparations - unlicensed use).
|
 NICE NG133: Hypertension in pregnancy: diagnosis and management |
|
| Lercanidipine |
|
Formulary
|
Tablets 10mg, 20mg A second line dihydropyridine calcium channel blocker when amlodipine is not tolerated (e.g. where patients develop significant ankle oedema) |
|
|
| Lacidipine |
|
Formulary
|
A second line dihydropyridine calcium channel blocker when amlodipine is not tolerated (e.g. where patients develop significant ankle oedema). For existing patients only |
|
|
| Diltiazem oral |
|
Formulary
|
Prescribe diltiazem modified-release preperations by brand name. Different hospital Trusts may stock different brands. Follow local Trust policy regarding brand switches. |
|
|
Links
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY* - LSC Statin Intolerance Pathway
- LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
- LSCMMG: Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- Renal: Enhanced Supportive Kidney Care Guideline